{{Rsnum
|rsid=3845905
|Gene=LRIG1
|Chromosome=3
|position=66475539
|Orientation=plus
|GMAF=0.2071
|Gene_s=LRIG1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 96.4 | 3.6 | 0.0
| HCB | 80.3 | 19.0 | 0.7
| JPT | 73.5 | 26.5 | 0.0
| YRI | 15.0 | 48.3 | 36.7
| ASW | 33.3 | 43.9 | 22.8
| CHB | 80.3 | 19.0 | 0.7
| CHD | 78.9 | 19.3 | 1.8
| GIH | 93.1 | 6.9 | 0.0
| LWK | 9.1 | 54.5 | 36.4
| MEX | 62.1 | 31.0 | 6.9
| MKK | 18.1 | 42.6 | 39.4
| TSI | 93.1 | 6.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=4E-6
  |OR=1.89
  |ORtxt=[1.433-2.503]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}